Huang Xing, Jin Lili, Deng Hao, Wu Dan, Shen Qing-Kun, Quan Zhe-Shan, Zhang Chang-Hao, Guo Hong-Yan
Key Laboratory of Natural Medicines of the Changbai Mountain, Affifiliated Ministry of Education, College of Pharmacy, Yanbian University, Yanji, China.
Front Pharmacol. 2022 Jul 11;13:920411. doi: 10.3389/fphar.2022.920411. eCollection 2022.
(), which has been used for thousands of years to treat cardiovascular diseases, is a well-known Chinese medicinal plant. The fat-soluble tanshinones in are important biologically active ingredients including tanshinone I, tanshinone IIA, dihydrotanshinone, and cryptotanshinone. Tanshinone I, a natural diterpenoid quinone compound widely used in traditional Chinese medicine, has a wide range of biological effects including anti-cancer, antioxidant, neuroprotective, and anti-inflammatory activities. To further improve its potency, water solubility, and bioavailability, tanshinone I can be used as a platform for drug discovery to generate high-quality drug candidates with unique targets and enhanced drug properties. Numerous derivatives of tanshinone I have been developed and have contributed to major advances in the identification of new drugs to treat human cancers and other diseases and in the study of related molecular mechanisms. This review focuses on the structural modification, total synthesis, and pharmacology of tanshinone I. We hope that this review will help understanding the research progress in this field and provide constructive suggestions for further research on tanshinone I.
()是一种著名的中药材,数千年来一直用于治疗心血管疾病。()中的脂溶性丹参酮是重要的生物活性成分,包括丹参酮I、丹参酮IIA、二氢丹参酮和隐丹参酮。丹参酮I是一种广泛应用于传统中药的天然二萜醌化合物,具有广泛的生物学效应,包括抗癌、抗氧化、神经保护和抗炎活性。为了进一步提高其效力、水溶性和生物利用度,丹参酮I可作为药物发现的平台,以产生具有独特靶点和增强药物特性的高质量候选药物。已经开发了许多丹参酮I的衍生物,这些衍生物为治疗人类癌症和其他疾病的新药鉴定以及相关分子机制的研究取得重大进展做出了贡献。本综述重点关注丹参酮I的结构修饰、全合成和药理学。我们希望本综述将有助于了解该领域的研究进展,并为丹参酮I的进一步研究提供建设性建议。